Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Identify the Dividend Aristocrats ETF with the lowest fees and understand how fee selection affects long-term performance.
27,609 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Markets retreat as geopolitical risk and currency headwinds weigh on miners and industrials. Linde and Southern Coppe...
An emerging critical iPhone exploit targets crypto apps as Morgan Stanley moves to shore up Bitcoin infrastructure wi...
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
A $3 million nest egg can fund comfortable retirement, but market swings and drawdown fears keep many retirees with m...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...
Airbnb announced a $2.5 billion bond offering, sending ABNB shares down about 4% as investors weigh a shift in the co...
As SpaceX eyes a public debut, one argument stands above the rest for why it could become the premier space stock in ...
A wave of zero-emission school bus mandates is accelerating across several states, putting districts under budget pre...
A sharp move in Nebius Group after announcing a massive capital raise highlights how debt and potential dilution can ...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
Oil hovers above $100 as the U.S. weighs a potential ground war in Iran. The move could ripple through gas prices, in...